Patent ID: 9547012
Date: 2017-01-17
CPC Classifications: G01N

Claim:
1. A method comprising: analyzing a serum sample from a test subject for a change in expression of a set of protein biomarkers, wherein the set of protein biomarkers comprises Chain A Albumin mutant R218H protein and one or more biomarkers selected from the group consisting of Haptoglobin HP-2a protein, Complement Factor I protein, Apolipoprotein E3 protein, Transthyretin dimer protein, Nucleoporin NUP 188 protein, Haptoglobin HP-1 protein, Albumin protein PRQ2044, Parkinson's LB acidic H2A protein, Apolipoprotein A-IV protein, Transthyretin Huntington Interacting Protein E, Complement C4b gamma chain protein, Fidgitin I protein, Immunoglobulin kappa light chain protein, Complement Factor H/Hs protein, Fidgitin II protein, Albumin protein PRQ2675, Haptoglobin related protein, and any combination thereof.